Proton therapy has been limited to laboratories in the Loma
Linda University Medical Center of Southern California Research Center opened
the first hospital proton in the world in 1990. Now the treatment to deal with
a more traditional choice for radiation therapists and their patients for
certain cancers.
Newly released study shows that this treatment option is
especially promising for patients with certain types of lung cancer and
prostate cancer.
While X-rays of the series and proton therapy may combat
cancer if administered in sufficient doses, X-ray therapy is not as accurate
and can cause damage to the surrounding healthy tissues and organs. This
requires doctors to use lower doses of radiation to minimize the negative side
effects.
Proton, on the other hand, provided the precise form of
radiation, according to the configuration of the cancer. Oncologists can
control the higher doses of proton beams and manage cancer while significantly
reducing damage to healthy tissues and vital organs.
A new study of 393 men, of Loma Linda and the Northeast
Proton Center at Massachusetts General Hospital in Boston led, suggests that
radiation oncologists with proton therapy can at higher doses of radiation
safety in patients with prostate cancer that power has improved the survival of
patients.
The disease-free survival at five years for those who
received high doses of proton radiation therapy has been promising. Only 17
percent had evidence of recurrence of prostate cancer, while 35 percent of
those receiving conventional dose group experienced a recurrence. Additionally,
less than 2 percent, the proton has been the way of side effects. X-ray
treatment selected
